Dr Narendra BS answers 10 questions on GLP-1 weight loss drugs
Updated
Updated · Hindustan Times · May 6
Dr Narendra BS answers 10 questions on GLP-1 weight loss drugs
7 articles · Updated · Hindustan Times · May 6
The Bengaluru endocrinologist at Aster Whitefield Hospital said Ozempic, Wegovy and Mounjaro can aid weight loss but need nutritional monitoring and strength training.
He highlighted risks including nausea, gallstones, pancreatitis, dehydration, muscle loss and possible bone-density decline, especially with low-protein diets, vitamin deficiencies, rapid weight loss and older age.
Dr Narendra said the drugs are not addictive but stopping them often leads to weight regain, and treatment decisions should depend on metabolic health, risk factors and sustained lifestyle changes.
If you regain 60% of weight after stopping Ozempic, is it a treatment or a lifelong metabolic subscription?
Could a genetic test soon predict if Ozempic will work for you or just make you sick?
With GLP-1s causing muscle loss, are Indians trading obesity for a future of frailty and bone fractures?